Traders Shift Rate Expectations Feds Next Move Could Be a Hike as Soon as December Rapid Growth of Roundhill Memory ETF Highlights Memory Chip Bottleneck in AI Buildup Paul Tudor Jones Boosts IREN Stake by 57 in Bet on AI Infrastructure Buildout Fed Minutes Reveal Officials Anticipate Rate Hikes If Inflation Persists Ferrari Luce EV A Strategic Shift That May Reshape the Supercar Icon UK Student Loan Inquiry Reveals Widespread Financial Distress Among Graduates TWST Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges LVLU Q1 2026 Earnings Massive EPS Miss Sends Stock Lower Immunome Q1 2026 Earnings NarrowerThanExpected Loss as Pipeline Progress Continues KTCC Q1 2026 Earnings Loss Per Share of 026 as Stock Declines 17 SPG Q1 2026 Earnings Modest EPS Miss Amid Stable Operational Performance GOOGL Q1 2026 Earnings EPS Miss Amidst AI Investment Pressures Geron Corporation GERN Edges Higher Testing Key Resistance After Modest Gains Arm Holdings Rides the AI Wave Strength at 30651 General Purpose Acquisition Corp Warrant GPACW Holds Steady at 028 Low Volatility in Focus Zimmer Biomet ZBH Holds Steady Near Support Modest Gains Amid Sector Pressure Main Street Capital MAIN Edges Higher as Stock Nears Key Resistance The Fight Against Foreign Developers Buying Caribbean Beaches Implications for Tourism and Real Estate Italian Diving Tragedy Highlights Potential Risks of Inadequate Equipment in Extreme Environments Surge in LongDated Treasury Yields Prompts Bond Investors to Rethink RiskFree Assumptions Kevin Warshs Potential Fed Overhaul A Shift in Wall Streets Plumbing and Market Intervention Rules Home Depot Comparable Sales Catch Up to Lowes Potentially Paving Way for Stock Performance Bitcoin Retreats to 74500 Poised for Weekly Decline as Geopolitical Concerns Mount Eli Lilly Stock Edges Higher After Announcing Nearly 4 Billion in VaccineRelated Deals UZF Q1 2026 Earnings EPS Surges Past Estimates by 43 Replimune Group REPL Rises 28 Approaching Resistance at 497 OCFC Q1 2026 Earnings Earnings Per Share Surpasses Expectations Shares Edge Higher GRI Bio Inc Q1 2026 Earnings EPS Misses Estimates as DevelopmentStage Company Faces Headwinds SYM Q1 2026 Earnings EPS Misses by 80 but Stock Climbs on Strategic Momentum ENVB Q4 2024 Earnings EPS Misses Estimates No Revenue Reported KURA Q1 2026 Earnings ClinicalStage Biotech Misses Wall Street Estimates Stock Slides ORLA Q1 2026 Earnings Narrow EPS Miss Pressures Shares SYF Q1 2026 Earnings Earnings Beat Estimates Amid Stable Credit Trends